Which DME Drug to Try First? Patients on Bevacizumab Can Successfully Transition to Aflibercept
October 2nd 2022The presentation focused on the Protocol AC trial, which considered whether step therapy had an impact on visual outcomes for patients starting on bevacizumab and switching to aflibercept later.
Read More
Posters Emphasize Prevalence and Need for Prompt Treatment of RVO
September 30th 2022Posters presented at the American Academy of Ophthalmology 2022 annual meeting showed that patients with retinal vein occlusion (RVO) are most likely older with higher diastolic blood pressure, and they require prompt treatment to help manage the disease.
Read More
Panel Reviews Health Inequities and Opportunities for Innovation Through Population Health Delivery
September 30th 2022A panel discussion at the 70th Annual Roy A. Bowers Pharmaceutical Conference addressed recent care delivery initiatives in New Jersey that aim to address health inequities and other population health concerns.
Read More
AAO Panel Offers Insight on Treatment Recommendations, In-Office Retina Surgery
September 30th 2022Speakers at a panel at the American Academy of Ophthalmology (AAO) 2022 conference spoke about future treatment options for patients in both minimally proven operations and in-office retina surgeries.
Read More
Advanced Imaging System Investigated for Faster Diagnosis of Skin Cancers
September 30th 2022This new study explored the diagnostic utility and accuracy of 2-photon fluorescence microscopy (TPFM) among nonmelanoma skin cancers, which included basal cell carcinoma and squamous cell carcinoma.
Read More
Dr Melissa O'Connor Reviews Considerations for Discharge in Home Health
September 30th 2022Melissa O'Connor, PhD, MBA, RN, FGSA, FAAN, endowed professor in Community and Home Health Nursing, M. Louise Fitzpatrick School of Nursing, Villanova University, and director, Gerontology Interest Group, discussed several factors for clinicians to consider in creating plans to discharge adults from skilled home health care.
Watch
CAR T-Cell Therapy Outcomes Are Not Impacted by Baseline Renal Function, Study Finds
September 30th 2022Renal outcomes and chimeric antigen receptor (CAR) T-cell therapy efficacy were unaffected by baseline renal status in a cohort of patients with diffuse large B cell lymphoma, but acute kidney injury during treatment was associated with worse clinical outcomes.
Read More
What We’re Reading: FDA Approves ALS Drug; Role of Microbes in Tumors; Suicides Increased in 2021
September 30th 2022The FDA approved AMX0035 (Relyvrio) for amyotrophic lateral sclerosis (ALS) Thursday; new research suggests looking at microbes and fungi within cancer tumors; US suicides increased in 2021 following a 2-year decrease in deaths by suicide.
Read More
Contributor: It’s Time to Talk About Paying Clinical Trial Participants More
September 30th 2022There is wide variation in the governance over research participant pay, and with rapid advances in technology enabling trial access, industry should step up and pay patients what they are worth, says Gunnar Esiason, a patient advocate living with cystic fibrosis.
Read More
What We’re Reading: Teen Substance Use Trends; Physician Burnout Increasing; Employee Mental Health
September 29th 2022Alcohol and cigarette use among teens declined between 1991 and 2019, while vape use increased; most US physicians reported at least 1 symptom of burnout between the end of 2021 and beginning of 2022; an estimated 12 billion annual workdays are lost due to depression and anxiety among employees.
Read More
CDC to Physicians: Watch for Severe Respiratory, Polio-Like Illness in Children
September 28th 2022The CDC this week noted what providers and parents have been seeing across the country: rising cases of a non-polio enterovirus causing severe respiratory illness and acute flaccid myelitis (AFM).
Read More
Pediatric ESS Effective, Safe to Treat Chronic Sinusitis With Nasal Polyps
September 28th 2022With a high recurrence rate following surgery to treat chronic sinusitis with nasal polyps, authors set out to investigate the effectiveness and safety of endoscopic sinus surgery (ESS) in a pediatric patient population.
Read More
FDA Committee Issues Positive Vote for RBX2660 in Recurrent Clostridioides difficile Infection
September 28th 2022An FDA advisory committee recently issued a positive vote for Ferring’s RBX2660, an investigational microbiota-based live biotherapeutic, for its potential in reducing recurrent Clostridioides difficile infection after antibiotic treatment.
Read More
Potential for PHC Necessitates Pediatric Cardiology Care for Children With PAH
September 28th 2022Outcomes following right heart catheterization in a pediatric patient population were analyzed, with emphasis placed on risk of adverse outcomes following the procedure, especially the development of pulmonary hypertensive crisis (PHC).
Read More